Table 1 Clinical data
Patient ID | No bone disease | Bisphosphonate tx (Y/N) |
|---|---|---|
1 (D) | PET: no focal myelomatous lesions | Y |
2 (D) | SS: No lytic lesions. | N |
3 (D) | SS: no lytic lesions. Diffuse osteopenia. | N |
4 (D) | SS: no evidence of lytic bone lesions | N |
5 (D) | SS: no lytic disease | N |
6 (D) | SS: no focal lytic lesions. | Y |
7 (D) | SS and MRI spine: no lytic lesions | N |
8 (D) | SS: no lytic lesions | Y |
9 (D) | Notes: no evidence of bone disease on SS. | N |
10 (D) | SS: no bone disease | N |
11 (V) | SS: no lytic lesions identified. | N. |
12 (V) | SS: no lytic lesions. MRI spine: no focal ltic lesions. | N |
13 (V) | SS: no lytic lesions. | N |
14 (V) | SS: no bone disease | N |
15 (V) | Notes: SS negative for lytic bone disease. | N |
16 (V) | SS and MRI spine: no lytic disease | N |
17 (V) | SS: no lytic lesions. | N |
18 (V) | SS: no lytic lesions | N |
19 (V) | SS (x2): negative metastatic bone series. | n/a |
20 (V) | SS: no lytic lesions or vert #s | N |
21 (V) | SS: no evidence of lytic disease | N |
22 (V) | SS: no lytic lesions | N |
23 (V) | SS: no lytic lesions | Y |
24 (V) | SS: no lytic lesions | N |
25 (V) | SS: no lytic lesions | Y |
26 (V) | SS: no lytic lesions. | N |
27 (V) | SS: no dominant lytic lesion seen. | N |
28 (V) | SS: no findings related to myeloma. | N |
29 (V) | Notes: no lytic lesions SS | N |
30 (V) | Notes (x2): no myeloma bone disease on SS. | N |
31 (V) | Notes: no evidence of lytic bone disease (SS). | Y |
32 (V) | SS: no evidence of lytic bone disease. | Y |
33 (V) | SS and CT abdo/pelvis: no lytic lesions | Y |
34 (V) | SS (x2): no lytic bone diesase. | Y |
35 (V) | SS: no focal lucencies suggestive of myeloma. | n/a |
36 (V) | SS: no lytic lesions | N |
37 (V) | SS: no lytic lesions | Y |
38 (V) | SS, CT spine and PET-CT: no lytic lesions. | N |
39 (V) | SS: no lytic lesions | N |
40 (V) | SS: no lytic disease | Y |
41 (V) | SS: no lytic lesions | Y |
Patient ID | High bone disease | Bisphosphonate tx (Y/N) |
42 (D) | Lytic lesions in hip on MRI, and in thorax on CT. | N |
43 (D) | Multiple lytic lesions, skull, pelvis, femur (SS) | Y |
44 (D) | MRI: widespread bone disease, including extramedullary involvement. | Y |
45 (D) | SS: multiple lucencies skull, pelcis, femora, compression #s spine. | n/a |
46 (D) | SS: diffuse lytic disease | N |
47 (D) | SS: C2 lesion and femoral neck lesions. | N |
48 (D) | SS: multiple involving skull, humeri, femora. | Y |
49 (D) | SS: multiple lucencies in the skull, and femoral lesion. | N |
50 (D) | Notes: Multiple lytic bone lesions | Y |
51 (D) | SS: multiple lytic lesions throughout skeleton. | Y |
52 (V) | SS: lucencies invol. Ribs, scapulae, T/L spines. | N |
53 (V) | Notes: multiple bony lesions with soft tissue extension. | n/a |
54 (V) | MRI: multiple spinal lesions | Y |
55 (V) | Notes: extensive bone involvement. | Y |
56 (V) | SS: lucencies of skull, humerus, femur, pelvis. | N |
57 (V) | SS: lesions of skull, ribs, humera, femur. | N |
58 (V) | SS: multiple lucencies femurs, humeri, skull | Y |
59 (V) | SS and MRI: skull, clavicle, vertebral lesions. | Y |
60 (V) | Vertebral, femoral, extramedullary (lung) lesions. | N |
61 (V) | SS: skull, humeri, vert lesions. | Y |
62 (V) | PET-CT: increased uptake left ilial and T12 vert, rib #s | N |
63 (V) | MRI: multiple compression #s spine, sacral lesions | Y |
64 (V) | SS: multiple lucencies, skull, humeri, femurs. | n/a |
65 (V) | SS: femurs, pelvis, skull luc, compressn # T9 | Y |
66 (V) | CT: lumbar spine, rib, pelvis, sternal lesions | Y |
67 (V) | MRI: multiple vertebral lesions | Y |
68 (V) | SS: lesions skull, pelvis, femora. | Y |
69 (V) | SS: skull, humrea, vert lesions | n/a |
70 (V) | Notes: scapular, pelvic and hip lesions. | Y |
71 (V) | SS: skull, vert, humeri lucencies | N |
72 (V) | SS/MRI: multiple lesions pelvis and lt humerus. | Y |
73 (V) | SS/MRIs: lumbar, thoracic and sacral lesions. | Y |
74 (V) | SS/PET: skull lesions and sternal plasmacytoma | N |
75 (V) | SS: lucencies femora, skull, humerus. | N |
76 (V) | SS: diffuse myel. involve. (skull, hum, fem, t spine, skull). | Y |
77 (V) | Notes: lucencies C/T spine and scapula. | N |
78 (V) | Notes: destructive lesions L2 and acetabulum. | Y |
79 (V) | SS: compressn #s spine, lucencies skull, femora, humeri. | Y |
80 (V) | PETCT: diffuse uptake spine, sternum, femora. | N |
81 (V) | MRI: T7-9 lesions with cord compression | N |
82 (V) | SS: lucencies femora, skull, humeri. | Y |
83 (V) | SS: lucencies of skull, clavicles, humera, T spine. | Y |
84 (V) | CT: 2 rib #s and compressn # T5 | N |
85 (V) | CT: innumerable lesions within axial and appendicular skeleton. | N |
86 (V) | SS: lucencies in vert, pelvis, humeri, femora. | N |
87 (V) | SS: lesions in skull, ribs, T spine, humeri. | Y |
88 (V) | SS: multiple lesions skull, pelvis, and T12 compressn #. | n/a |
89 (V) | Notes: review of outside films demonstrates extensive bony disease | N |
90 (V) | SS: Numerous lesions in skull and extremeties. | N |
Patient ID | Pre-malignant myeloma | Bisphosphonate tx (Y/N) |
91 (V) | MGUS | N |
92 (V) | MGUS | N |
93 (V) | MGUS | N |
94 (V) | MGUS | N |
95 (V) | MGUS | N |
96 (V) | MGUS | N |
97 (V) | MGUS | N |
98 (V) | MGUS | N |
99 (V) | MGUS | N |
100 (V) | SMM | N |
101 (V) | SMM | N |
102 (V) | SMM | N |
103 (V) | SMM | N |
104 (V) | SMM | N |
105 (V) | SMM | N |
106 (V) | SMM | N |
107 (V) | SMM | N |
108 (V) | SMM | N |
109 (V) | SMM | N |
110 (V) | SMM | N |
111 (V) | SMM | N |